News articles for B. Braun Medical Inc.:
Monday, January 23, 2012
B. Braun Becomes the First to Deliver FDA-Approved 2g Cefazolin
BETHLEHEM, Pa., Jan. 23, 2012 /PRNewswire/ -- B. Braun Medical Inc. (B. Braun), a leader in infusion therapy and pain management, said today it received U.S. Food and Drug Administration (FDA) approval for 2g Cefazolin for Injection USP and Dextrose Injection USP in B. Braun's DUPLEX® Drug ...
read more Wednesday, October 19, 2011